Semaglutide Tied to 21% Fewer Psychiatric Stays in Bipolar Swedes

“Semaglutide, the drug behind Ozempic and Wegovy, may have benefits that extend well beyond weight loss and diabetes. In a large Swedish study of nearly 15,000 people with bipolar disorder, its use was linked to a 21% lower risk of psychiatric hospitalization.” From ScienceDaily. The post Semaglutide Tied to Psychiatric Benefits for Bipolar Swedes appeared first on Human Progress.